GVPS believes in utilizing tools that will enhance the accuracy of assessment and treatment. Since November 2011, Dr. Gonzales-Vigilar has incorporated use of a saliva-based test called Genomind gene testing when indicated as part of her individualized clinical care. This is a simple yet personalized and comprehensive tool that provides information about how psychotropic medications may affect a particular patient’s brain, and how the patient’s body metabolizes a wide array of medications. You can learn more about Genomind testing at www.genomind.com
